• It is orally bioavailable, unlike most peptides.
• Molecular weight: ~159 Da.
• Mechanism: Blocks NNMT → increases NAD⁺ → activates fat‑cell metabolism.

Characteristics of 5‑Amino‑1MQ

5‑Amino‑1MQ characteristics include:

1. Small‑Molecule NNMT Inhibitor

It directly binds to NNMT’s active site, preventing the methylation of nicotinamide and preserving SAM and NAD⁺ pools.

2. Targets Fat‑Cell Metabolism

Unlike GLP‑1 agonists (which suppress appetite), 5‑Amino‑1MQ reprograms adipocytes to burn energy more efficiently.

3. Oral Administration

Capsules are the standard form—no reconstitution, no injections.

4. Works at the Cellular Level

By restoring NAD⁺, it activates SIRT1, improves mitochondrial function, and increases lipid oxidation.

How 5‑Amino‑1MQ Works (Mechanism of Action)

Mechanism involves several metabolic pathways:

1. NNMT Inhibition

NNMT consumes SAM and diverts nicotinamide away from NAD⁺ synthesis. Overexpression leads to “metabolically dormant” fat cells.

2. NAD⁺ Restoration

Blocking NNMT increases NAD⁺ availability, which is essential for:

• Mitochondrial energy production
• Sirtuin activation
• Fat oxidation

3. Increased Energy Expenditure

Higher NAD⁺ levels allow fat cells to burn stored energy instead of storing it.

4. Reduced Adipocyte Size

Preclinical studies show smaller fat cells and reduced fat mass without affecting appetite.

5‑Amino‑1MQ 10 mg

5‑Amino‑1MQ 10 mg refers to a common capsule strength used in research settings. Because 5‑Amino‑1MQ is orally active, 10 mg capsules are often used as part of multi‑capsule daily protocols.

Key Points

• 10 mg is a unit dose, not a full daily protocol.
• Researchers typically combine multiple capsules to reach study‑level ranges.
• Capsule form ensures stability and ease of use.

(Important: This is not medical advice; dosage information is strictly descriptive of research literature.)

5‑Amino‑1MQ 10 mg Dosage 

5‑Amino‑1MQ dosage varies widely in research contexts. Human clinical dosing is not established, but preclinical and community protocols provide general ranges.

1. Standard Research Ranges

• 50–150 mg/day orally is commonly referenced in research communities.

2. Cycle Length

• 8–12 weeks is the typical research cycle.

3. Onset Timeline

• Early metabolic changes: 2–4 weeks
• Visible fat‑loss changes: 4–8 weeks

4. Administration

• Oral capsules once or twice daily.

5. Safety Notes

• Human clinical trials are limited.
• Most data comes from animal studies and anecdotal reports.

5‑Amino‑1MQ Benefits

5‑Amino‑1MQ benefits are among the reasons it has become one of the most discussed metabolic compounds.

Preclinical studies show:

• Reduced fat mass
• Smaller adipocyte size
• Increased energy expenditure

2. Preserves Lean Muscle

Unlike appetite‑suppressing drugs, 5‑Amino‑1MQ does not reduce food intake or muscle mass.

3. Boosts NAD⁺ Levels

Higher NAD⁺ supports:

• Mitochondrial function
• Cellular repair
• Longevity pathways

4. Improves Insulin Sensitivity

Research suggests improved glucose utilization and metabolic flexibility.

5. Supports Muscle Performance

Animal studies show improved grip strength and faster muscle recovery.

6. Complements GLP‑1 Agonists

Because it targets fat‑cell metabolism directly, it pairs well with GLP‑1 therapies in research contexts.

Comparison With Other Metabolic Compounds | 5 Amino 1mq​ 

A structured comparison helps clarify where 5‑Amino‑1MQ fits.

Safety & Side Effects | 5 Amino 1mq​

Reported side effects are generally mild:

• Gastrointestinal discomfort
• Headache (rare)
• Injection‑site irritation (only for non‑oral forms)

Contraindications include the following:

• Pregnancy/breastfeeding
• Severe liver disease
• Methylation disorders

Final Summary

5‑Amino‑1MQ is a small‑molecule NNMT inhibitor that increases NAD⁺ levels, enhances fat‑cell metabolism, and supports energy expenditure. Research suggests benefits for fat loss, metabolic health, muscle performance, and cellular energy.

• 5‑Amino‑1MQ 10 mg refers to capsule strength.
• Dosage in research settings typically ranges 50–150 mg/day.
• Benefits include fat‑loss support, improved insulin sensitivity, NAD⁺ restoration, and preserved muscle